Get the Daily Brief
Latest Biotech News
Biotech market and M&A / capital-access headwinds
Biopharma executives say capital access remains the binding constraint even as confidence improves for partnering and deal activity. A new BIO-Europe Biopharma C-Suite Agenda Survey finds...
Regulatory and safety scrutiny for approved rare-disease and antiviral medicines
Patient advocates and some experts are raising renewed safety alarm around Neurocrine Biosciences’ rare-disease therapy Vykat XR (for Prader-Willi syndrome). A STAT+ follow-up reports growing...
Oncology clinical readouts: immuno-oncology, radiation strategies, and imaging-adjacent tools
Multiple oncology updates focused on treatment sequencing and disease control. A randomized phase 3 trial reported that fractionated stereotactic radiosurgery after brain metastasis surgery...
Cell therapy and precision immunotherapy preclinical/clinical pipeline signals
A rare clinical signal in cell therapy highlights how donor-derived CAR-T approaches can generate remissions after transplant failure. A Chinese clinical study reported complete remissions in 13...
Infectious disease countermeasures: diagnostics and trial-adjacent prevention
In diagnostics, Johns Hopkins researchers reported clinical validation support for the first FDA-cleared rapid urine test aimed at invasive aspergillosis, designed to speed identification by...
Biomarkers and diagnostics for precision oncology
Imaging and blood-based biomarkers are moving toward earlier decision points. A meta-analysis reported that radiomics models using CT-image features plus clinical variables can predict high-risk...
Novel immunotherapy targets and mechanisms in inflammation and cancer
Mechanistic immunology continues to surface actionable biology. A study described how the viral RNA sensor MDA5 can act as an immune-evasion ally for tumors, and that disabling it can trigger...
Neurodegeneration biology: early risk genes, imaging correlates, and mechanistic brakes
Neurodegeneration research emphasized both earlier risk mapping and mechanistic tissue drivers. Stress-tagged ubiquitin marked a soluble oligomeric tau population in Alzheimer’s brains and...
Regenerative medicine and wound healing technologies
A regenerative medicine study highlighted nanobiomaterial delivery for difficult wound contexts. Researchers reported that energy-boosted endothelial cells release GAS6-carrying exosomes that...
Manufacturing and platform moves: formulation translation and AI-enabled rapid design
Pharma formulation translation remained a centerpiece of platform innovation. The Journal of Pharmaceutical Investigation announced a January 2027 special issue focused on translational advances...
Allogeneic CAR-T retreat and trial halts
Caribou Biosciences said it is reviewing strategic alternatives while cutting resources and halting its two clinical-phase allogeneic CAR-T programs. The company also announced additional...
FDA approval for Asahi Kasei’s oral HSV pill after big deal
Asahi Kasei Therapeutics won FDA approval for Hovilpri (approved for treating lesions caused by herpes simplex virus infection), a daily oral pill that follows the company’s acquisition of AiCuris...
Bristol Myers’ mixed Phase 3 readouts for lung fibrosis and RayzeBio
Bristol Myers Squibb reported a pair of Phase 3 wins tied to its fibrosis and RayzeBio programs, while noting an experimental lung drug, admilparant, posted mixed results that left analysts...
CMS 2026 drug pricing rule raises manufacturer reporting load
The Centers for Medicare & Medicaid Services’ 2026 Physician Fee Schedule Final Rule expands documentation requirements for drug manufacturers reporting average sales price (ASP) and related...
New trial evidence doubles survival for small cell lung cancer brain metastases
A randomized Phase 3 trial reported that stereotactic radiosurgery nearly doubled median survival in patients with small cell lung cancer and brain metastases, compared with hippocampal-avoidant...
Radiotherapy intensification after brain metastasis surgery reduces recurrence
In the Alliance trial, postoperative radiosurgery delivered in three to five sessions reduced recurrence at the surgical site compared with a single-session approach and was linked to longer...
FDA-cleared rapid urine test for invasive aspergillosis
Johns Hopkins Medicine researchers reported clinical validation supporting the first FDA-cleared rapid urine test designed to aid diagnosis of invasive aspergillosis. The development targets a key...
Meta-analysis: hemoglobin transfusion threshold may improve acute brain injury outcomes
A Bayesian network meta-analysis of six randomized trials involving 2,599 patients with acute brain injury found that a transfusion threshold of 9 g/dL ranked highest for functional outcome. The...
Health-data policy: companion diagnostics bridging validation for pembrolizumab
Researchers reported post-marketing bridging studies confirming that two commercially available companion diagnostics reliably identify patients with dMMR/MSI-H tumors eligible for pembrolizumab....
New diagnostics or care: laser-powered beads to detect colorectal cancer biomarker quickly
Osaka Metropolitan University developed a laser-assisted system using “laser-powered beads” to detect CEACAM-5 in diluted blood plasma within minutes. The approach targets low-abundance biomarker...